PAR1 and PAR4 exert opposite effects on tumor growth and metastasis of esophageal squamous cell carcinoma via STAT3 and NF-κB signaling pathways

• Published in: Cancer cell international Vol. 21; no. 1; pp. 1 - 637
• Main Authors: Zhao, Jia, Jin, Guangyu, Liu, Xudong, Wu, Kai, Yang, Yang, He, Zhanfeng, Liu, Donglei, Zhang, Chunyang, Zhu, Dengyan, Jiao, Jia, Li, Xiangnan, Zhao, Song
• Format: Journal Article
• Language: English
• Published: London BioMed Central 29-11-2021; BMC
• Subjects: 1-Phosphatidylinositol 3-kinase; AKT protein; Antibodies; Apoptosis; Cancer metastasis; Carcinogenesis; Cell culture; Cell proliferation; Environmental factors; Esophageal cancer; Esophageal squamous cell carcinoma; Esophagus; Flow cytometry; Genomes; Immunofluorescence; Immunoprecipitation; Intracellular; MAP kinase; Medical prognosis; Metastases; Metastasis; NF-κB protein; Plasmids; Primary Research; Protease-activated receptors; Proteinase; Proteinase-activated receptor 1; Proteins; Receptor mechanisms; Signal transduction; Squamous cell carcinoma; Stat3 protein; STAT3/NF-κB; Statistical analysis; Tumors; Variance analysis; Wound healing; United States > US; China
• DOI: 10.1186/s12935-021-02354-4
• EISSN: 1475-2867

Background Esophageal carcinogenesis is a multifactorial process in which genetic and environmental factors interact to activate intracellular signals, leading to the uncontrolled survival and growth of esophageal squamous cell carcinoma (ESCC) cells. The intracellular pathways of ESCC cells could be regulated by proteinase activated-receptors (PARs), which are comprised of four receptors (i.e., PAR-1, PAR-2, PAR-3, and PAR-4). Therefore, the function and possible mechanism of PAR1 and PAR4 in the progression of ECSS were explored in our study. Methods First, we detected the expression levels of PAR1 and PAR4 in 27 cases of ESCC specimens and cell lines by RT-qPCR, IHC and western blot. Meanwhile, the correlation between PAR1/PAR4 expression levels, clinicopathological characteristics, and disease free survival was analyzed. Then, we constructed PAR1/PAR4 knockdown cell models and investigated the role of PAR1/PAR4 knockdown on the proliferation, apoptosis, changes of calcium flow, and metastasis of ESCC cells via MTT, flow cytometry, transwell and wound healing assays in vitro. Further, an experimental metastasis model in vivo was established to explore the role of stable PAR1/PAR4 knockdown on the growth and metastasis of ESCC cells. Finally, the role of nSMase2 in the activation of NF-κB induced by PAR4 and the role of NF-κB and STAT3 signaling pathways in the PAR1/PAR4-mediated tumor promoting or suppressive functions were measured by immunoprecipitation, western blot and immunofluorescence assays. Results First, the integrated results demonstrated the expression levels of PAR1 and PAR4 are inversely proportional in ESCC. PAR1 potently enhanced tumor growth and metastasis, while PAR4 had an inhibitory effect. Further, the co-activation of STAT3 and NF-κB was involved in the PAR1 activation-induced tumor promoting effect, while only NF-κB participated in the PAR4 activation-induced tumor inhibitory effect in ESCC. To be specific, FAK/PI3K/AKT/STAT3/NF-κB signaling mediated PAR1 activation-induced tumor promoting effect and nSMase2/MAPK/NF-κB signaling mediated PAR4 activation-induced tumor inhibitory effect. Conclusions Overall, the study has provided new insights into the potential implication of PAR1 and PAR4 in the pathogenesis of ESCC. Besides, FAK/PI3K/AKT/STAT3/NF-κB and nSMase2/MAPK/NF-κB pathways may be novel targets for regulating tumor growth and metastasis in ESCC patients.